PMDA drug package insert
プランルカスト錠112.5mg「CEO」
PMDA Prescription drug · セオリア ファーマ株式会社 · package insert Mar 29, 2024
Key facts
| Brand names | プランルカスト錠112.5mg「CEO」, プランルカスト錠225mg「CEO」 |
|---|---|
| Nonproprietary names | プランルカスト水和物 |
| Companies | 製造販売元／セオリア ファーマ株式会社, 販売／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ロイコトリエン受容体拮抗剤; 気管支喘息・アレルギー性鼻炎治療剤 |
| Therapeutic category codes | 87449 |
| YJ codes | 4490017F1053, 4490017F2050 |
| Approval numbers | 22400AMX01202, 22400AMX01203 |
| Package insert edition | 第1版 |
| Package insert date | Mar 29, 2024 |
| PMDA document key | 380999_4490017F1053_1 |
| PMDA company code | 380999 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: